|
REPIN1 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.68709490822039E-12 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.30559999770242E-08 |
| Normal-vs-Stage2 |
9.63369999995578E-07 |
| Normal-vs-Stage3 |
N/A |
| Normal-vs-Stage4 |
8.964300E-03 |
| Stage1-vs-Stage2 |
9.965600E-01 |
| Stage1-vs-Stage3 |
N/A |
| Stage1-vs-Stage4 |
8.068400E-01 |
| Stage2-vs-Stage3 |
N/A |
| Stage2-vs-Stage4 |
8.341600E-01 |
| Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.02438066310151E-12 |
| Normal-vs-AfricanAmerican |
1.784000E-01 |
| Normal-vs-Asian |
1.469750E-01 |
| Caucasian-vs-AfricanAmerican |
6.469000E-01 |
| Caucasian-vs-Asian |
6.284600E-01 |
| AfricanAmerican-vs-Asian |
5.876800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.94810000026169E-07 |
| Normal-vs-Female |
1.71349999744663E-08 |
| Male-vs-Female |
7.896800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.4496000000045E-05 |
| Normal-vs-Extreme_Weight |
3.03830000047967E-07 |
| Normal-vs-Obese |
8.042700E-04 |
| Normal-vs-Extreme_Obese |
N/A |
| Normal_Weight-vs-Extreme_Weight |
1.299000E-01 |
| Normal_Weight-vs-Obese |
1.156830E-01 |
| Normal_Weight-vs-Extreme_Obese |
N/A |
| Extreme_Weight-vs-Obese |
8.204000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
N/A |
| Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.958760E-01 |
| Normal-vs-Age(41-60Yrs) |
2.04129999999969E-05 |
| Normal-vs-Age(61-80Yrs) |
1.93360000233511E-08 |
| Normal-vs-Age(81-100Yrs) |
1.172410E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.249600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.409240E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.010400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.152400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.519200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.618000E-01 |
|
|
CHOL : Cholangiocarcinoma
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
N/A |
| Normal-vs-Grade 2 |
4.276300E-02 |
| Normal-vs-Grade 3 |
2.830200E-01 |
| Normal-vs-Grade 4 |
1.000000E+00 |
| Grade 1-vs-Grade 2 |
N/A |
| Grade 1-vs-Grade 3 |
N/A |
| Grade 1-vs-Grade 4 |
N/A |
| Grade 2-vs-Grade 3 |
1.165230E-01 |
| Grade 2-vs-Grade 4 |
4.276300E-02 |
| Grade 3-vs-Grade 4 |
2.830200E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.89039894848975E-11 |
| Normal-vs-N1 |
2.677700E-02 |
| N0-vs-N1 |
2.975200E-01 |
|
|
